theranostics
Theradiag 2021 Revenues up 7 Percent
The revenue increase was driven by higher sales of the company's theranostic products including its Tracker line of therapeutic drug monitoring tests.
Theradiag Preliminary H1 2021 Revenues up 12 Percent
The revenue increase was driven by increased sales of the company's theranostic products, with strong growth in the US market.
Theradiag 2020 Revenues up 8 Percent
The French firm attributed the revenue increase to strong sales of its theranostics products, which include its therapeutic drug monitoring tests.
Theradiag 2019 Revenues Grow 8 Percent
The company' theranostics revenue were up 10 percent while its IVD revenues grew 6 percent. It posted a profit of €349,000 for 2019.
Theradiag Posts 9 Percent Increase in H1 2019 Revenues
The revenue increase was driven by increased sales across all of the French diagnostic and theranostics firm's business segments.
Jan 16, 2019
Theradiag Gets CE Mark for Cosentyx Response Kit
Sep 21, 2018
Theradiag Reports 9 Percent Decline in H1 Revenues
Oct 16, 2017